| Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms SA Wang, RP Hasserjian, PS Fox, HJ Rogers, JT Geyer, ... Blood, The Journal of the American Society of Hematology 123 (17), 2645-2651, 2014 | 223 | 2014 |
| Correlation of mutation profile and response in patients with myelofibrosis treated with ruxolitinib KP Patel, KJ Newberry, R Luthra, E Jabbour, S Pierce, J Cortes, R Singh, ... Blood, The Journal of the American Society of Hematology 126 (6), 790-797, 2015 | 194 | 2015 |
| Treatment of bipolar depression with deep TMS: results from a double-blind, randomized, parallel group, sham-controlled clinical trial DF Tavares, ML Myczkowski, RL Alberto, L Valiengo, RM Rios, P Gordon, ... Neuropsychopharmacology 42 (13), 2593-2601, 2017 | 150* | 2017 |
| Prognostic Significance of Circulating RET M918T Mutated Tumor DNA in Patients With Advanced Medullary Thyroid Carcinoma GJ Cote, C Evers, MI Hu, EG Grubbs, MD Williams, T Hai, DY Duose, ... The Journal of Clinical Endocrinology & Metabolism 102 (9), 3591-3599, 2017 | 70 | 2017 |
| Salvaging the supernatant: next generation cytopathology for solid tumor mutation profiling S Roy-Chowdhuri, M Mehrotra, AM Bolivar, R Kanagal-Shamanna, ... Modern Pathology 31 (7), 1036-1045, 2018 | 63 | 2018 |
| Melanoma arising in association with blue nevus: a clinical and pathologic study of 24 cases and comprehensive review of the literature S Loghavi, JL Curry, CA Torres-Cabala, D Ivan, KP Patel, M Mehrotra, ... Modern Pathology 27 (11), 1468-1478, 2014 | 63 | 2014 |
| Identification of a novel fusion gene, IRF2BP2-RARA, in acute promyelocytic leukemia CC Yin, N Jain, M Mehrotra, J Zhagn, A Protopopov, Z Zuo, N Pemmaraju, ... Journal of the National Comprehensive Cancer Network 13 (1), 19-22, 2015 | 61 | 2015 |
| Targeted next-generation sequencing of endometrial cancer and matched circulating tumor DNA: identification of plasma-based, tumor-associated mutations in early stage patients AM Bolivar, R Luthra, M Mehrotra, W Chen, BA Barkoh, P Hu, W Zhang, ... Modern Pathology 32 (3), 405-414, 2019 | 53 | 2019 |
| Centrifuged supernatants from FNA provide a liquid biopsy option for clinical next‐generation sequencing of thyroid nodules W Ye, B Hannigan, S Zalles, M Mehrotra, BA Barkoh, MD Williams, ... Cancer Cytopathology 127 (3), 146-160, 2019 | 39 | 2019 |
| Liquid biopsy assay for lung carcinoma using centrifuged supernatants from fine-needle aspiration specimens B Hannigan, W Ye, M Mehrotra, V Lam, A Bolivar, S Zalles, BA Barkoh, ... Annals of Oncology 30 (6), 963-969, 2019 | 36 | 2019 |
| ETV6–FLT3 fusion gene-positive, eosinophilia-associated myeloproliferative neoplasm successfully treated with sorafenib and allogeneic stem cell transplant L Falchi, M Mehrotra, KJ Newberry, LM Lyle, G Lu, KP Patel, R Luthra, ... Leukemia 28 (10), 2090-2092, 2014 | 36 | 2014 |
| Detection of somatic mutations in cell-free DNA in plasma and correlation with overall survival in patients with solid tumors M Mehrotra, RR Singh, S Loghavi, DY Duose, BA Barkoh, C Behrens, ... Oncotarget 9 (12), 10259, 2018 | 35 | 2018 |
| Anti-invasive efficacy and survival benefit of the YAP-TEAD inhibitor verteporfin in preclinical glioblastoma models AM Barrette, H Ronk, T Joshi, Z Mussa, M Mehrotra, A Bouras, ... Neuro-oncology 24 (5), 694-707, 2022 | 34 | 2022 |
| Insights from response to tyrosine kinase inhibitor therapy in a rare myeloproliferative neoplasm with CALR mutation and BCR-ABL1 S Loghavi, N Pemmaraju, R Kanagal-Shamanna, M Mehrotra, ... Blood, The Journal of the American Society of Hematology 125 (21), 3360-3363, 2015 | 31 | 2015 |
| A phase I study of panobinostat and ruxolitinib in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF) J Mascarenhas, BK Marcellino, M Lu, M Kremyanskaya, F Fabris, L Sandy, ... Leukemia research 88, 106272, 2020 | 28 | 2020 |
| Versatile ion S5XL sequencer for targeted next generation sequencing of solid tumors in a clinical laboratory M Mehrotra, DY Duose, RR Singh, BA Barkoh, J Manekia, MA Harmon, ... PLoS One 12 (8), e0181968, 2017 | 27 | 2017 |
| Study of preanalytic and analytic variables for clinical next-generation sequencing of circulating cell-free nucleic acid M Mehrotra, RR Singh, W Chen, RSP Huang, AA Almohammedsalim, ... The Journal of Molecular Diagnostics 19 (4), 514-524, 2017 | 27 | 2017 |
| Identification of clinically important chromosomal aberrations in acute myeloid leukemia by array-based comparative genomic hybridization M Mehrotra, R Luthra, F Ravandi, RL Sargent, BA Barkoh, R Abraham, ... Leukemia & lymphoma 55 (11), 2538-2548, 2014 | 27 | 2014 |
| Intratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinoma: challenges for personalized therapy RR Singh, P Murugan, LR Patel, H Voicu, SY Yoo, T Majewski, ... Modern Pathology 28 (9), 1225-1235, 2015 | 26 | 2015 |
| Novel enriched pathways in superficial malignant peripheral nerve sheath tumours and spindle/desmoplastic melanomas G Jour, NK Andeen, R al‐Rohil, PP Aung, M Mehrotra, D Duose, B Hoch, ... The Journal of pathology 244 (1), 97-106, 2018 | 22 | 2018 |
